Tenivac Injection, Suspension
Product Images NDC 49281-215

4 FDA label images from Sanofi Vaccines Us Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Tenivac (NDC 49281-215). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sanofi Vaccines Us Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Principal Display Panel (0.5 mL Vial Label)

Principal Display Panel (0.5 mL Vial Label)
TENIVAC Td vaccine single-dose 0.5 mL injection label for intramuscular use, containing Tetanus and Diphtheria Toxoids Adsorbed. The label states use for ages 7 years and older, with NDC 49281-215-58, and is produced by Sanofi Pasteur Limited. The label includes barcodes and space for lot number and expiration date.*
FDA Label Image

Principal Display Panel (10 Vial Package)

Principal Display Panel (10 Vial Package)
TENIVAC Tetanus and Diphtheria Toxoids Adsorbed vaccine label for injection suspension. Contains 10 single-dose vials, each 0.5 mL, with strengths of 5 and 2 Lf per 0.5 mL. The label specifies intramuscular administration for persons 7 years and older. Manufactured by Sanofi Pasteur Limited and distributed by Sanofi Pasteur Inc. Storage instructions include refrigeration at 2° to 8°C and warnings not to freeze. The label also instructs to shake well before use and discard unused portions.*
FDA Label Image

Principal Display Panel (0.5 mL Syringe Label)

Principal Display Panel (0.5 mL Syringe Label)
TENIVAC single-dose 0.5 mL injection suspension label showing Tetanus and Diphtheria Toxoids Adsorbed vaccine for intramuscular use. The label specifies use for patients 7 years and older, marks for prescription use only, and includes the labeler Sanofi Pasteur Limited. The label also features the NDC 49281-215-88 and a pull tab.*
FDA Label Image

Principal Display Panel (10 Syringe Package)

Principal Display Panel (10 Syringe Package)
TENIVAC Tetanus and Diphtheria Toxoids Adsorbed injection, suspension, is presented in a carton for 10 single-dose prefilled syringes of 0.5 mL each. The label indicates intramuscular use for persons 7 years and older, with storage instructions to keep between 2° to 8°C and warnings to shake well and not freeze. Manufactured by Sanofi Pasteur Limited, the package highlights the inclusion of tetanus and diphtheria toxoids with aluminum phosphate adjuvant.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.